Author Title [ Type(Desc)] Year
Filters: Author is Ansell, Stephen M  [Clear All Filters]
Journal Article
Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Villasboas JC, Markovic SN. Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis. Leuk Res. 2019;81:1-9.
Fayad L, Ansell SM, Advani R, Coiffier B, Stuart R, Bartlett NL, Forero-Torres A, Kuliczkowski K, Belada D, Ng E, et al. Dacetuzumab plus R-ICE as salvage therapy for patients with DLBCL relapsing after R-CHOP: a randomized, double-blind, placebo-controlled Phase 2b trial. Leuk Lymphoma. 2015:1-24.
Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, Markovic SN. Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation. Bone Marrow Res. 2013;2013:658371.
Ansell SM. Hodgkin Lymphoma: 2020 update on diagnosis, risk-stratification, and management. Am J Hematol. 2020.
Porrata LF, Burgstaler EA, Winters JL, Jacob EK, Gastineau DA, Suman VJ, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, et al. Immunologic Autograft Engineering and Survival in Non-Hodgkin's Lymphoma. Biol Blood Marrow Transplant. 2016.
Moreira CL, M Sidiqi H, Buadi FK, Litzow MR, Gertz MA, Dispenzieri A, Russell SJ, Ansell SM, Stegall MD, Prieto M, et al. Long-term Outcomes of Sequential Hematopoietic Stem Cell Transplantation and Kidney Transplantation: Single-center Experience. Transplantation. 2020.